Benzamide, 3-fluoro-N-(4-fluorophenyl)-4-hydroxy-N-(4-hydroxyphenyl)- manufacturers
- Capesaris
-
- $155.00
-
2026-07-27
- CAS:938067-78-8
- Purity: 99.80%
- Supply Ability: 10g
|
| | Benzamide, 3-fluoro-N-(4-fluorophenyl)-4-hydroxy-N-(4-hydroxyphenyl)- Basic information |
| | Benzamide, 3-fluoro-N-(4-fluorophenyl)-4-hydroxy-N-(4-hydroxyphenyl)- Chemical Properties |
| Boiling point | 555.1±50.0 °C(Predicted) | | density | 1.429±0.06 g/cm3(Predicted) | | pka | 6.72±0.20(Predicted) | | form | Solid | | color | White to off-white |
| | Benzamide, 3-fluoro-N-(4-fluorophenyl)-4-hydroxy-N-(4-hydroxyphenyl)- Usage And Synthesis |
| Uses | GTX-758 is an orally active, nonsteroidal, selective agonist of ERα. GTX-758 plays an important role in castration resistant prostate cancer (CRPC) research[1]. | | IC 50 | ERα | | References | [1] M.S. Steiner, et al. 923P - GTX-758, An Oral ERa Agonist, Increases Sex Hormone Binding Globulin, Reduces Free T and Decreases PSA in Patients with Castration Resistant Prostate Cancer. Annals of Oncology Volume 23, Supplement 9, September 2012, Page ix304 |
| | Benzamide, 3-fluoro-N-(4-fluorophenyl)-4-hydroxy-N-(4-hydroxyphenyl)- Preparation Products And Raw materials |
|